It’s rewarding to see our Spanish biotech client BioSystems move on from the business development programme we’ve been delivering in China to set up its own Chinese operation.
We’ve been working with Barcelona-based BioSystems since early 2018 to help the company expand in China.
Our work has included:
- market assessments to give BioSystems a thorough understanding of the opportunities in China’s clinical chemistry, fermented beverage and bioprocessing sectors
- sales programmes to drive take-up of its technologies
- partner support
- representation of the company at exhibitions including CACLP, China’s largest in vitro diagnostics (IVD) expo, and
- initiation of research programmes with three Chinese institutes
This has established a strong foothold in the country for BioSystems and paved the way for it to set up its own Chinese company – Shanghai BioSystems Biotechnology Ltd – and recruit its first two China-based employees.
The operation will provide BioSystems with its own Shanghai-based interface with its Chinese partners, customers and suppliers. Its new team will also build on the relationships we initiated for the company with Chinese biotech scientists, healthcare professionals and government authorities.
BioSystems’ CEO, Pau Vila Cases, said: “We’re proud to be opening our own Chinese operation – and grateful to Intralink for having helped us to develop our business in China to make this possible.
Over the last three years, they’ve demonstrated excellent market knowledge and local relationships. And they’ve operated as a highly professional team – despite all the upheaval COVID-19 has brought to the challenge of international growth.
We hope to have the opportunity to collaborate with Intralink further as we continue our growth programme in China.”
To discuss the opportunities to grow your medtech business in China, Japan, South Korea or Taiwan, get in touch with Graham Barker at graham.barker@intralinkgroup.com